A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

Clinical trial NCT07099898 · RECRUITING

Trial details

NCT number: NCT07099898
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Lung

Start date: 2025-08-11
Primary completion: 2027-11-05
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.